Blog
RSS FeedPosted by Michael Wonder on 24 Oct 2020
Health Canada releases final version of controversial regulations for controlling drug prices
23 October 2020 - After months of delay, Health Canada has released a final version of new regulations that are ...
Posted by Michael Wonder on 06 Oct 2020
1 October 2020 price disclosure - confirmed prices
6 October 2020 - Confirmed 1 October 2020 prices resulting from the 2020 October Cycle of Price Disclosure has now been ...
Posted by Michael Wonder on 10 Sep 2020
Active ingredient prescribing
10 September 2020 - Active Ingredient Prescribing will ensure consumers receive consistent and standardised medicines information. ...
Posted by Michael Wonder on 05 Sep 2020
International reference pricing: discounts down under far surpass U.S. drug price concessions
1 September 2020 - At 30,000 feet, the view of Australia’s healthcare system does not look too different from our own ...
Posted by Michael Wonder on 20 Aug 2020
Could the coronavirus vaccine be mandatory in Australia? Experts say it's possible.
20 August 2020 - News this week that Australia could have 25 million doses of the so-called "Oxford vaccine" available ...
Posted by Michael Wonder on 10 Aug 2020
Return some excess drug revenues to employers, CLHIA says in submission to PMPRB
10 August 2020 - In its submission to the Patented Medicine Prices Review Board’s draft guidelines, the Canadian Life and ...
Posted by Michael Wonder on 04 Aug 2020
Innovative Medicines Canada responds to the revised draft PMPRB Guidelines consultation
4 August 2020 - The Patented Medicine Prices Review Board's revised Guidelines will result in patients losing access to innovative ...
Posted by Michael Wonder on 28 Jul 2020
2020 October price disclosure cycle – indicative prices
28 July 2020 - Indicative 1 October 2020 prices resulting from the 2020 October Cycle of Price Disclosure have now been ...
Posted by Michael Wonder on 14 Jul 2020
PMPRB changes within scope of Patent Act, rules federal court in judicial review
13 July 2020 - The Federal Court has upheld reforms to the Patented Medicines Pricing Review Board that updated the ...
Posted by Michael Wonder on 10 Jul 2020
Proposal to modify PHARMAC’s approach to competitive procurement
10 July 2020 - PHARMAC is proposing to standardise the way that it contracts for pharmaceuticals as a result of ...
Posted by Michael Wonder on 09 Jul 2020
PHARMAC to remove medicine dispensing restrictions
9 July 2020 - Most funded medicines will return to all at once dispensing because PHARMAC is removing most of ...
Posted by Michael Wonder on 07 Jul 2020
Lessons from the impact of price regulation on the pricing of anti-cancer drugs in Germany
7 July 2020 - Worldwide spending on prescription drugs has increased dramatically in recent years. Although this increase has been particularly ...
Posted by Michael Wonder on 29 Jun 2020
IMC responds to Federal Court decision regarding PMPRB regulatory changes
29 June 2020 - Innovative Medicines Canada released the following statement today in response to the Federal Court of Canada’s ...
Posted by Michael Wonder on 22 Jun 2020
PMPRB publishes new draft guidelines, launches 30 day consultation
22 June 2020 - As reported earlier this month, the Patented Medicine Prices Review Board has published a new draft ...
Posted by Michael Wonder on 18 Jun 2020
Government authorises use of dexamethasone for COVID-19
18 June 2020 - The UK has authorised immediate use of dexamethasone on the NHS, widening access to the first ...